☆ 4.7 Article

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Related references

Note: Only part of the references are listed.

Article Substance Abuse

Clinical management of cannabis withdrawal

Jason P. Connor et al.

Summary: This review examines the diagnosis, prevalence, course, and management of cannabis withdrawal. The onset of symptoms typically occurs within 24-48 hours after cessation and peak between days 2-6. The most common symptoms include anxiety, irritability, disturbed sleep, depressed mood, and loss of appetite. Currently, there are no approved medications for medically assisted withdrawal, but some promising pharmacological agents have been explored in controlled trials.

ADDICTION (2022)

Add to Collection

Review Behavioral Sciences

Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

Kristine Romer Thomsen et al.

Summary: Research suggests that adolescence and emerging adulthood are peak periods for cannabis use, with cannabis use disorder linked to adverse outcomes. While approved pharmacotherapies for CUD are lacking, cannabinoid-based treatments show promise in helping youth with CUD.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Add to Collection

Article Substance Abuse

COVID-19's Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry

Ekaterina Fedorova et al.

Summary: Few qualitative studies have examined the impact of COVID-19 on cannabis and alcohol use, and overall well-being among cannabis users. The research found that the increase in cannabis and alcohol use during the COVID-19 pandemic was mainly attributed to changes in employment and staying at home, with loneliness playing a significant role in the coping strategies.

JOURNAL OF DRUG ISSUES (2022)

Add to Collection

Article Pharmacology & Pharmacy

Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort

Julie Weiss et al.

Summary: This study aimed to investigate the prevalence, characteristics, and care difficulties of cannabinoid hyperemesis syndrome (CHS) in emergency departments. The findings showed that patients with CHS spent more time in emergency departments, had more frequent visits, and faced challenges in follow-up and cannabis cessation treatment post-discharge.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)

Add to Collection

Article Substance Abuse

Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study

Sameer Imtiaz et al.

Summary: In the context of the ongoing COVID-19 pandemic in Canada, the overall population's cannabis use remained stable, but a significant proportion of cannabis users increased their usage. Risk characteristics associated with an increase in cannabis use included age, education level, and concerns about the pandemic's impact on personal finances.

JOURNAL OF ADDICTION MEDICINE (2021)

Add to Collection

Review Psychiatry

When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services

Candice E. Crocker et al.

Summary: Cannabis use is associated with the development and exacerbation of mental illness, especially the risk of psychotic disorder. In emergency situations, cannabis-related adverse mental health events such as anxiety, suicidal thoughts, and psychotic symptoms are significant, particularly in youth and young adults. The differences in impact between alcohol and cannabis on emergency mental health services highlight the need for tailored interventions based on individual risk factors.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Letter Medicine, General & Internal

National Retail Sales of Alcohol and Cannabis During the COVID-19 Pandemic in Canada

James MacKillop et al.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Substance Abuse

Cannabis sales increases during COVID-19: Findings from Alaska, Colorado, Oregon, and Washington

Gillian L. Schauer et al.

Summary: During the COVID-19 pandemic, cannabis sales in Alaska, Colorado, Oregon, and Washington have increased significantly compared to the previous years, with Washington reaching a three-year peak in sales. The data suggests a notable rise in cannabis consumption during the pandemic period.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Add to Collection

Article Medicine, General & Internal

Changes in Emergency Department Encounters for Vomiting After Cannabis Legalization in Colorado

George Sam Wang et al.

Summary: The legalization of cannabis in Colorado has been associated with an increase in vomiting-related emergency department visits. Counties with more recreational dispensaries saw a higher incidence of vomiting-related ED visits, while counties with a high number of medical marijuana dispensaries had slower increases in such visits. It is important for healthcare professionals to be aware of cannabis hyperemesis syndrome and inquire about cannabis use when appropriate.

JAMA NETWORK OPEN (2021)

Add to Collection

Review Psychiatry

The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review

Maryam Sorkhou et al.

Summary: This systematic review examined the evidence for adverse behavioral sequalae of cannabis in healthy individuals, finding that factors such as frequency of use, THC content, age of onset, and cumulative exposure can contribute to negative outcomes. The strongest evidence was found for the impact of cannabis on psychosis and psychosocial functioning, highlighting the importance of understanding vulnerability to these adverse effects in order to prevent and treat problematic cannabis use.

FRONTIERS IN PSYCHIATRY (2021)

Add to Collection

Article Psychiatry

Cannabis and COVID-19: Reasons for Concern

Margriet W. van Laar et al.

FRONTIERS IN PSYCHIATRY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms

Marieka V. DeVuono et al.

CANNABIS AND CANNABINOID RESEARCH (2020)

Add to Collection

Review Medicine, General & Internal

Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management

Mahesh Gajendran et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults

Imran Aziz et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Review Neurosciences

Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective

Ziva D. Cooper et al.

NEUROPSYCHOPHARMACOLOGY (2018)

Add to Collection

Review Emergency Medicine

Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area

Jeremy M. Hernandez et al.

CANADIAN JOURNAL OF EMERGENCY MEDICINE (2018)

Add to Collection

Article Emergency Medicine

CANNABINOID HYPEREMESIS SYNDROME: PATHOPHYSIOLOGY AND TREATMENT IN THE EMERGENCY DEPARTMENT

John R. Richards

JOURNAL OF EMERGENCY MEDICINE (2018)

Add to Collection

Review Psychiatry

Psychosis and synthetic cannabinoids

Huiqiong Deng et al.

PSYCHIATRY RESEARCH (2018)

Add to Collection

Article Medicine, Research & Experimental

Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?

John R. Richards

MEDICAL HYPOTHESES (2017)

Add to Collection

Article Multidisciplinary Sciences

Measuring cannabis consumption: Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)

Carrie Cuttler et al.

PLOS ONE (2017)

Add to Collection

Article Multidisciplinary Sciences

Short Report: TRPV1-polymorphism 1911 A>G alters capsaicin-induced sensory changes in healthy subjects

Julia Forstenpointner et al.

PLOS ONE (2017)

Add to Collection

Article Gastroenterology & Hepatology

Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome

Andrzej Wasilewski et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

The Role of the Endocannabinoid System in the Brain-Gut Axis

Keith A. Sharkey et al.

GASTROENTEROLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Gastroduodenal Disorders

Vincenzo Stanghellini et al.

GASTROENTEROLOGY (2016)

Add to Collection

Article Pharmacology & Pharmacy

A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy

Michelle Sexton et al.

CANNABIS AND CANNABINOID RESEARCH (2016)

Add to Collection

Article Medicine, General & Internal

Cannabinoid Hyperemesis: A Case Series of 98 Patients

Douglas A. Simonetta et al.

MAYO CLINIC PROCEEDINGS (2012)

Add to Collection

Article Substance Abuse

An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)

Simon J. Adamson et al.

DRUG AND ALCOHOL DEPENDENCE (2010)

Add to Collection

Review Chemistry, Medicinal

Cannabinoid-Induced Hyperemesis: A Conundrum-From Clinical Recognition to Basic Science Mechanisms

Nissar A. Darmani

PHARMACEUTICALS (2010)

Add to Collection

Article Medicine, General & Internal

A brief measure for assessing generalized anxiety disorder -: The GAD-7

Robert L. Spitzer et al.

ARCHIVES OF INTERNAL MEDICINE (2006)

Add to Collection

Article Health Care Sciences & Services

Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders

AM Rentz et al.

QUALITY OF LIFE RESEARCH (2004)

Add to Collection

Article Endocrinology & Metabolism

Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis

S Patel et al.

ENDOCRINOLOGY (2004)

Add to Collection

Article Health Care Sciences & Services

Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders:: The PAGI-QOL©

C de la Loge et al.

QUALITY OF LIFE RESEARCH (2004)

Add to Collection

Article Gastroenterology & Hepatology

Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse

JH Allen et al.

GUT (2004)

Add to Collection

Article Health Care Sciences & Services

Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms

DA Revicki et al.

QUALITY OF LIFE RESEARCH (2004)

Add to Collection

Article Health Care Sciences & Services

The PHQ-9 - Validity of a brief depression severity measure

K Kroenke et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.